The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
-
Page/Page column 36-37
(2010/11/25)
More Articles about upstream products of 921204-89-9